Study

Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD. – Cost Effective Supplements

Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/23478193


Conclusion of this study

The results demonstrate a statistically significant and clinically relevant superiority of add-on therapy with EPs 7630 over placebo and a good long-term tolerability in the treatment of moderate to severe COPD. EPs 7630 prolonged time to exacerbations and reduced exacerbation frequency and antibiotic use. Trial Registration No.: ISRCTN01681733.


Supplements analyzed in this study

African Geranium

Health conditions analyzed in this study

No health conditions information for this study.

Functions related to this study

Overall health


Slightly Positive
African Geranium


Body systems related to this study


Respiratory System
Scroll to top